0001593968-21-001633.txt : 20210616 0001593968-21-001633.hdr.sgml : 20210616 20210616190127 ACCESSION NUMBER: 0001593968-21-001633 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210614 FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ignelzi Troy A. CENTRAL INDEX KEY: 0001579829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 211022813 MAIL ADDRESS: STREET 1: C/O ESPERION THERAPEUTICS, INC. STREET 2: 46701 COMMERCE CENTER DRIVE CITY: PLYMOUTH STATE: MI ZIP: 48170 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-06-14 0001771917 Karuna Therapeutics, Inc. KRTX 0001579829 Ignelzi Troy A. C/O KARUNA THERAPEUTICS, INC. 99 HIGH STREET, 26TH FLOOR BOSTON MA 02110 false true false false Chief Financial Officer Common Stock 2021-06-16 4 M false 2248 9.2 A 15248 D Common Stock 2021-06-16 4 S false 2248 129.45 D 13000 D Common Stock 2021-06-14 4 M false 900 9.2 A 13900 D Common Stock 2021-06-14 4 S false 900 132.52 D 13000 D Common Stock 2021-06-16 4 M false 352 9.2 A 13352 D Common Stock 2021-06-16 4 S false 352 128.4 D 13000 D Option (right to buy) 9.20 2021-06-16 4 M false 2248 0 D 2029-03-28 Common Stock 2248 10031 D Option (right to buy) 9.20 2021-06-14 4 M false 900 0 D 2029-04-07 Common Stock 900 1605 D Option (right to buy) 9.20 2021-06-16 4 M false 352 0 D 2029-04-07 Common Stock 352 1253 D This option vests and becomes exercisable in thirty-six equal monthly installments beginning on April 1, 2019. /s/ Troy Ignelzi 2021-06-16